BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 12379890)

  • 1. Identification of amplified clonal T cell populations in the blood of patients with chronic graft-versus-host disease: positive correlation with response to photopheresis.
    French LE; Alcindor T; Shapiro M; McGinnis KS; Margolis DJ; Porter D; Leonard DG; Rook AH; Foss F
    Bone Marrow Transplant; 2002 Oct; 30(8):509-15. PubMed ID: 12379890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unique abnormalities of CD4(+) and CD8(+) central memory cells associated with chronic graft-versus-host disease improve after extracorporeal photopheresis.
    Yamashita K; Horwitz ME; Kwatemaa A; Nomicos E; Castro K; Sokolic R; Foster SF; Garofalo M; Choi U; Ryherd M; Brown MR; Leitman SF; Wayne AS; Fowler DH; Bishop MR; Childs RW; Barrett AJ; Pavletic SZ; Malech HL
    Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 2):22-30. PubMed ID: 16399598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stable clonal expansion of the T-cell receptor V beta 6, V beta 17 and V beta 19 T cells in a cGVHD case using genescan analysis.
    Li Y; Du X; Xu M; Zhang T; Yang L; Chen S
    Chin Med J (Engl); 2001 May; 114(5):489-92. PubMed ID: 11780410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracorporeal photopheresis therapy in the management of steroid-refractory or steroid-dependent cutaneous chronic graft-versus-host disease after allogeneic stem cell transplantation: feasibility and results.
    Apisarnthanarax N; Donato M; Körbling M; Couriel D; Gajewski J; Giralt S; Khouri I; Hosing C; Champlin R; Duvic M; Anderlini P
    Bone Marrow Transplant; 2003 Mar; 31(6):459-65. PubMed ID: 12665841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maturation state of dendritic cells during the extracorporeal photopheresis and its relevance for the treatment of chronic graft-versus-host disease.
    Spisek R; Gasova Z; Bartunkova J
    Transfusion; 2006 Jan; 46(1):55-65. PubMed ID: 16398731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evidence for TCR Vbeta clonal expansion T cells in a patient with cGVHD after unrelated donor BMT].
    Du X; Li Y; Weng J; Lu Z; Su J; Lin W; Huang Z
    Zhonghua Xue Ye Xue Za Zhi; 2000 Aug; 21(8):406-8. PubMed ID: 11877011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracorporeal photoimmunotherapy for the treatment of steroid refractory progressive chronic graft-versus-host disease.
    Ilhan O; Arat M; Arslan O; Ayyildiz E; Sanli H; Beksac M; Ozcan M; Gürman G; Akan H
    Transfus Apher Sci; 2004 Jun; 30(3):185-7. PubMed ID: 15172621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracorporeal photopheresis normalizes some lymphocyte subsets (including T regulatory cells) in chronic graft-versus-host-disease.
    Bladon J; Taylor P
    Ther Apher Dial; 2008 Aug; 12(4):311-8. PubMed ID: 18789119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective study of extracorporeal photopheresis in steroid-refractory or steroid-resistant extensive chronic graft-versus-host disease: analysis of response and survival incorporating prognostic factors.
    Foss FM; DiVenuti GM; Chin K; Sprague K; Grodman H; Klein A; Chan G; Stiffler K; Miller KB
    Bone Marrow Transplant; 2005 Jun; 35(12):1187-93. PubMed ID: 15852025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of extensive chronic graft-versus-host disease with extracorporeal photochemotherapy.
    Bisaccia E; Palangio M; Gonzalez J; Adler KR; Scarborough R; Goldberg SL; Rowley SD
    J Clin Apher; 2006 Oct; 21(3):181-7. PubMed ID: 16607632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonal T-cell populations are frequent in the skin and blood of patients with systemic sclerosis.
    Kreuter A; Höxtermann S; Tigges C; Hahn SA; Altmeyer P; Gambichler T
    Br J Dermatol; 2009 Oct; 161(4):785-90. PubMed ID: 19523172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracorporeal photopheresis in chronic graft-versus-host disease.
    Foss FM; Gorgun G; Miller KB
    Bone Marrow Transplant; 2002 May; 29(9):719-25. PubMed ID: 12040467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating endothelial progenitor cells decreased in patients with sclerodermatous chronic graft-versus-host disease.
    Shimura K; Ashihara E; Shimazaki C; Matsunaga S; Taniguchi K; Uchiyama H; Matsumoto Y; Kimura S; Matsubara H; Taniwaki M; Maekawa T
    Biol Blood Marrow Transplant; 2008 Apr; 14(4):426-37. PubMed ID: 18342785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetic of regulatory CD25high and activated CD134+ (OX40) T lymphocytes during acute and chronic graft-versus-host disease after allogeneic bone marrow transplantation.
    Sanchez J; Casaño J; Alvarez MA; Roman-Gomez J; Martin C; Martinez F; Gomez P; Serrano J; Herrera C; Torres A
    Br J Haematol; 2004 Sep; 126(5):697-703. PubMed ID: 15327522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-4-producing CD8(+) T cells may be an immunological hallmark of chronic GVHD.
    Nakamura K; Amakawa R; Takebayashi M; Son Y; Miyaji M; Tajima K; Nakai K; Ito T; Matsumoto N; Zen K; Kishimoto Y; Fukuhara S
    Bone Marrow Transplant; 2005 Oct; 36(7):639-47. PubMed ID: 16044136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased donor CD86+CD14+ cells in the bone marrow and peripheral blood of patients with chronic graft-versus-host disease.
    Arpinati M; Chirumbolo G; Marzocchi G; Baccarani M; Rondelli D
    Transplantation; 2008 Jun; 85(12):1826-32. PubMed ID: 18580477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased interleukin 10 and increased interferon-gamma production in patients with chronic graft-versus-host disease after allogeneic bone marrow transplantation.
    Körholz D; Kunst D; Hempel L; Söhngen D; Heyll A; Bönig H; Göbel U; Zintl F; Burdach S
    Bone Marrow Transplant; 1997 Apr; 19(7):691-5. PubMed ID: 9156246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered Toll-like receptor 9 responses in circulating B cells at the onset of extensive chronic graft-versus-host disease.
    She K; Gilman AL; Aslanian S; Shimizu H; Krailo M; Chen Z; Reid GS; Wall D; Goldman F; Schultz KR
    Biol Blood Marrow Transplant; 2007 Apr; 13(4):386-97. PubMed ID: 17382246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early complete donor hematopoietic chimerism in peripheral blood indicates the risk of extensive graft-versus-host disease.
    Balon J; Hałaburda K; Bieniaszewska M; Reichert M; Bieniaszewski L; Piekarska A; Pawłowski R; Hellmann A
    Bone Marrow Transplant; 2005 Jun; 35(11):1083-8. PubMed ID: 15821766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors of chronic graft-versus-host disease after allogeneic blood stem-cell transplantation.
    Pavletic SZ; Smith LM; Bishop MR; Lynch JC; Tarantolo SR; Vose JM; Bierman PJ; Hadi A; Armitage JO; Kessinger A
    Am J Hematol; 2005 Apr; 78(4):265-74. PubMed ID: 15795914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.